{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:11:04Z","timestamp":1793970664906,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Coordination of Superior Level Staff Improvement","award":["Finance code 001"],"award-info":[{"award-number":["Finance code 001"]}]},{"name":"Brazilian National Council for Scientific and Technological Development"},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"crossref","award":["VPPCB-005-FIO-20-2-65"],"award-info":[{"award-number":["VPPCB-005-FIO-20-2-65"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Carlos Chagas Foundation for the Advancement of Science of the State of Rio de Janeiro","award":["E-26\/200.157\/2023"],"award-info":[{"award-number":["E-26\/200.157\/2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08632-9","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T12:58:18Z","timestamp":1751806698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Central nervous system and systemic inflammatory networks associated with acute neurological outcomes in COVID-19"],"prefix":"10.1038","volume":"15","author":[{"given":"Nicole Lardini","family":"Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Victor Carvalho","family":"Deus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yago C\u00f4rtes Pinheiro","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Carvalho","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Ot\u00e1vio","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Nascimento","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Tulius Teixeira","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ot\u00e1vio Melo","family":"Esp\u00edndola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,6]]},"reference":[{"key":"8632_CR1","first-page":"e8790","volume":"12","author":"D Azim","year":"2020","unstructured":"Azim, D., Nasim, S., Kumar, S., Hussain, A. & Patel, S. Neurological consequences of 2019-nCoV infection: A comprehensive literature review. Cureus 12, e8790 (2020).","journal-title":"Cureus"},{"key":"8632_CR2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","volume":"19","author":"MA Ellul","year":"2020","unstructured":"Ellul, M. A. et al. Neurological associations of COVID-19. Lancet Neurol. 19, 767\u2013783 (2020).","journal-title":"Lancet Neurol."},{"key":"8632_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26207","author":"RK Garg","year":"2020","unstructured":"Garg, R. K., Paliwal, V. K. & Gupta, A. Encephalopathy in patients with COVID-19: A review. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.26207 (2020).","journal-title":"J. Med. Virol."},{"key":"8632_CR4","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","volume":"382","author":"J Helms","year":"2020","unstructured":"Helms, J. et al. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 382, 2268\u20132270 (2020).","journal-title":"N. Engl. J. Med."},{"key":"8632_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127","author":"L Mao","year":"2020","unstructured":"Mao, L. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127 (2020).","journal-title":"JAMA Neurol."},{"key":"8632_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijid.2020.10.044","volume":"102","author":"OM Esp\u00edndola","year":"2021","unstructured":"Esp\u00edndola, O. M. et al. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development. Int. J. Infect. Dis. 102, 155\u2013162 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"8632_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12941-022-00525-3","volume":"21","author":"M Sobczak","year":"2022","unstructured":"Sobczak, M. & Pawliczak, R. COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: A meta-analysis of randomized clinical trials. Ann. Clin. Microbiol. Antimicrob. 21, 32 (2022).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"8632_CR8","doi-asserted-by":"publisher","first-page":"e2220385","DOI":"10.1001\/jamanetworkopen.2022.20385","volume":"5","author":"MK Steele","year":"2022","unstructured":"Steele, M. K. et al. Estimated Number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021. JAMA Netw. Open 5, e2220385 (2022).","journal-title":"JAMA Netw. Open"},{"key":"8632_CR9","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","volume":"329","author":"T Thaweethai","year":"2023","unstructured":"Thaweethai, T. et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA 329, 1934\u20131946 (2023).","journal-title":"JAMA"},{"key":"8632_CR10","doi-asserted-by":"publisher","first-page":"100127","DOI":"10.1016\/j.bbih.2020.100127","volume":"7","author":"G Vargas","year":"2020","unstructured":"Vargas, G. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives. Brain, Behav. Immun. Health 7, 100127 (2020).","journal-title":"Brain, Behav. Immun. Health"},{"key":"8632_CR11","doi-asserted-by":"publisher","first-page":"1169740","DOI":"10.3389\/fnins.2023.1169740","volume":"17","author":"A Sha","year":"2023","unstructured":"Sha, A. & Chen, H. Infection routes, invasion mechanisms, and drug inhibition pathways of human coronaviruses on the nervous system. Front. Neurosci. 17, 1169740 (2023).","journal-title":"Front. Neurosci."},{"key":"8632_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","volume":"16","author":"A Pezzini","year":"2020","unstructured":"Pezzini, A. & Padovani, A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 16, 636\u2013644 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"8632_CR13","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/v14122629","volume":"14","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2022","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as, C. et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: A systematic review of the literature. Viruses 14, 2629 (2022).","journal-title":"Viruses"},{"key":"8632_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/ana.26041","volume":"89","author":"OM Esp\u00edndola","year":"2021","unstructured":"Esp\u00edndola, O. M. et al. Inflammatory cytokine patterns Associated with neurological diseases in coronavirus disease 2019. Ann. Neurol. 89, 1041\u20131045 (2021).","journal-title":"Ann. Neurol."},{"key":"8632_CR15","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1177\/0333102420965963","volume":"40","author":"MTT Silva","year":"2020","unstructured":"Silva, M. T. T. et al. Isolated intracranial hypertension associated with COVID-19. Cephalalgia 40, 1452\u20131458 (2020).","journal-title":"Cephalalgia"},{"key":"8632_CR16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"A Venkatesan","year":"2013","unstructured":"Venkatesan, A. et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: Consensus statement of the international encephalitis consortium. Clin. Infect. Dis. 57, 1114\u20131128 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"8632_CR17","doi-asserted-by":"publisher","first-page":"1004023","DOI":"10.3389\/fimmu.2022.1004023","volume":"13","author":"GP Jardim-Santos","year":"2022","unstructured":"Jardim-Santos, G. P. et al. Unbalanced networks and disturbed kinetics of serum soluble mediators associated with distinct disease outcomes in severe COVID-19 patients. Front Immunol 13, 1004023 (2022).","journal-title":"Front Immunol"},{"key":"8632_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ijid.2020.05.123","volume":"96","author":"OM de Esp\u00edndola","year":"2020","unstructured":"de Esp\u00edndola, O. M. et al. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid. Int. J. Infect. Dis. 96, 567\u2013569 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"8632_CR19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1056\/NEJMc2011400","volume":"383","author":"VG Puelles","year":"2020","unstructured":"Puelles, V. G. et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 383, 590\u2013592 (2020).","journal-title":"N. Engl. J. Med."},{"key":"8632_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMc2019373","volume":"383","author":"IH Solomon","year":"2020","unstructured":"Solomon, I. H. et al. Neuropathological features of Covid-19. N. Engl. J. Med. 383, 989\u2013992 (2020).","journal-title":"N. Engl. J. Med."},{"key":"8632_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25783","author":"A Pilotto","year":"2020","unstructured":"Pilotto, A. et al. Steroid-responsive encephalitis in coronavirus disease 2019. Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.25783 (2020).","journal-title":"Ann. Neurol."},{"key":"8632_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainresbull.2018.11.017","volume":"146","author":"P Luo","year":"2019","unstructured":"Luo, P., Chu, S.-F., Zhang, Z., Xia, C.-Y. & Chen, N.-H. Fractalkine\/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases. Brain Res. Bull. 146, 12\u201321 (2019).","journal-title":"Brain Res. Bull."},{"key":"8632_CR23","doi-asserted-by":"publisher","first-page":"10541","DOI":"10.1523\/JNEUROSCI.18-24-10541.1998","volume":"18","author":"AG Rabchevsky","year":"1998","unstructured":"Rabchevsky, A. G. et al. A role for transforming growth factor alpha as an inducer of astrogliosis. J. Neurosci. 18, 10541\u201310552 (1998).","journal-title":"J. Neurosci."},{"key":"8632_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1006\/nbdi.2001.0432","volume":"8","author":"I Schnurra","year":"2001","unstructured":"Schnurra, I., Bernstein, H. G., Riederer, P. & Braunewell, K. H. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer\u2019s disease and promotes cell death and tau phosphorylation in vitro: A link between calcium sensors and Alzheimer\u2019s disease?. Neurobiol. Dis. 8, 900\u2013909 (2001).","journal-title":"Neurobiol. Dis."},{"key":"8632_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-022-01122-4","volume":"14","author":"S Halbgebauer","year":"2022","unstructured":"Halbgebauer, S. et al. Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer\u2019s and other neurodegenerative diseases. Alzheimers Res. Ther. 14, 175 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"8632_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbrc.2004.08.055","volume":"323","author":"P Gierke","year":"2004","unstructured":"Gierke, P. et al. Expression analysis of members of the neuronal calcium sensor protein family: Combining bioinformatics and Western blot analysis. Biochem. Biophys. Res. Commun. 323, 38\u201343 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"8632_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jneuroim.2008.01.010","volume":"195","author":"D Azoulay","year":"2008","unstructured":"Azoulay, D., Urshansky, N. & Karni, A. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. J. Neuroimmunol. 195, 186\u2013193 (2008).","journal-title":"J. Neuroimmunol."},{"key":"8632_CR28","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.jinf.2020.06.038","volume":"81","author":"D Azoulay","year":"2020","unstructured":"Azoulay, D. et al. Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration. J. Infect. 81, e79\u2013e81 (2020).","journal-title":"J. Infect."},{"key":"8632_CR29","doi-asserted-by":"publisher","first-page":"H434","DOI":"10.1152\/ajpheart.2001.280.1.H434","volume":"280","author":"W Wang","year":"2001","unstructured":"Wang, W., Dentler, W. L. & Borchardt, R. T. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am. J. Physiol. Heart Circ. Physiol. 280, H434-440 (2001).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"8632_CR30","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/ncb1486","volume":"8","author":"J Gavard","year":"2006","unstructured":"Gavard, J. & Gutkind, J. S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8, 1223\u20131234 (2006).","journal-title":"Nat. Cell Biol."},{"key":"8632_CR31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3389\/fimmu.2019.01265","volume":"10","author":"N Lotfi","year":"2019","unstructured":"Lotfi, N. et al. Roles of GM-CSF in the pathogenesis of autoimmune diseases: An update. Front. Immunol. 10, 1265 (2019).","journal-title":"Front. Immunol."},{"key":"8632_CR32","doi-asserted-by":"publisher","first-page":"e2213253","DOI":"10.1001\/jamanetworkopen.2022.13253","volume":"5","author":"A Ed\u00e9n","year":"2022","unstructured":"Ed\u00e9n, A. et al. Viral antigen and inflammatory biomarkers in cerebrospinal fluid in patients With COVID-19 infection and neurologic symptoms compared with control participants without infection or neurologic symptoms. JAMA Netw. Open 5, e2213253 (2022).","journal-title":"JAMA Netw. Open"},{"key":"8632_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neurol.2022.11.002","volume":"179","author":"H Chaumont","year":"2023","unstructured":"Chaumont, H. et al. Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes. Rev. Neurol. (Paris) 179, 208\u2013217 (2023).","journal-title":"Rev. Neurol. (Paris)"},{"key":"8632_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00011-003-1181-9","volume":"52","author":"G Hoffmann","year":"2003","unstructured":"Hoffmann, G., Wirleitner, B. & Fuchs, D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm. Res. 52, 313\u2013321 (2003).","journal-title":"Inflamm. Res."},{"key":"8632_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/196432","volume":"2013","author":"M Eisenhut","year":"2013","unstructured":"Eisenhut, M. Neopterin in diagnosis and monitoring of infectious diseases. J. Biomark. 2013, 1\u201310 (2013).","journal-title":"J. Biomark."},{"key":"8632_CR36","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/neuonc\/nov092","volume":"17","author":"A Viaccoz","year":"2015","unstructured":"Viaccoz, A. et al. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma. Neuro Oncol. 17, 1497\u20131503 (2015).","journal-title":"Neuro Oncol."},{"key":"8632_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2015.10.003","volume":"71","author":"K Ghisoni","year":"2015","unstructured":"Ghisoni, K., de Martins, R. P., Barbeito, L. & Latini, A. Neopterin as a potential cytoprotective brain molecule. J. Psychiatr. Res. 71, 134\u2013139 (2015).","journal-title":"J. Psychiatr. Res."},{"key":"8632_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.freeradbiomed.2017.11.022","volume":"115","author":"R de Paula Martins","year":"2018","unstructured":"de Paula Martins, R. et al. Neopterin preconditioning prevents inflammasome activation in mammalian astrocytes. Free Radic. Biol. Med. 115, 371\u2013382 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"8632_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4161\/viru.2.2.15480","volume":"2","author":"L Vande Walle","year":"2011","unstructured":"Vande Walle, L., Kanneganti, T.-D. & Lamkanfi, M. HMGB1 release by inflammasomes. Virulence 2, 162\u2013165 (2011).","journal-title":"Virulence"},{"key":"8632_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","volume":"11","author":"H Yang","year":"2020","unstructured":"Yang, H., Wang, H. & Andersson, U. Targeting inflammation driven by HMGB1. Front. Immunol. 11, 484 (2020).","journal-title":"Front. Immunol."},{"key":"8632_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10020-023-00717-3","volume":"29","author":"W Ren","year":"2023","unstructured":"Ren, W., Zhao, L., Sun, Y., Wang, X. & Shi, X. HMGB1 and Toll-like receptors: Potential therapeutic targets in autoimmune diseases. Mol. Med. 29, 117 (2023).","journal-title":"Mol. Med."},{"key":"8632_CR42","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3389\/fimmu.2018.03022","volume":"9","author":"C Savarin","year":"2018","unstructured":"Savarin, C. & Bergmann, C. C. Fine tuning the cytokine storm by IFN and IL-10 following neurotropic coronavirus encephalomyelitis. Front. Immunol. 9, 3022 (2018).","journal-title":"Front. Immunol."},{"key":"8632_CR43","doi-asserted-by":"publisher","first-page":"104474","DOI":"10.1016\/j.yexmp.2020.104474","volume":"115","author":"E Lavi","year":"2020","unstructured":"Lavi, E. & Cong, L. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp. Mol. Pathol. 115, 104474 (2020).","journal-title":"Exp. Mol. Pathol."},{"key":"8632_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1084\/jem.20061738","volume":"204","author":"MA Kleinschek","year":"2007","unstructured":"Kleinschek, M. A. et al. IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 204, 161\u2013170 (2007).","journal-title":"J. Exp. Med."},{"key":"8632_CR45","doi-asserted-by":"publisher","first-page":"31834","DOI":"10.1074\/jbc.M109.025940","volume":"284","author":"Y Sonobe","year":"2009","unstructured":"Sonobe, Y. et al. Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner. J. Biol. Chem. 284, 31834\u201331842 (2009).","journal-title":"J. Biol. Chem."},{"key":"8632_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1479-5876-10-239","volume":"10","author":"L Aloe","year":"2012","unstructured":"Aloe, L., Rocco, M. L., Bianchi, P. & Manni, L. Nerve growth factor: From the early discoveries to the potential clinical use. J. Transl. Med. 10, 239 (2012).","journal-title":"J. Transl. Med."},{"key":"8632_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cytogfr.2004.01.004","volume":"15","author":"RWC Wong","year":"2004","unstructured":"Wong, R. W. C. & Guillaud, L. The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Fact. Rev. 15, 147\u2013156 (2004).","journal-title":"Cytokine Growth Fact. Rev."},{"key":"8632_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","volume":"7","author":"Y Fan","year":"2022","unstructured":"Fan, Y. et al. SARS-CoV-2 Omicron variant: Recent progress and future perspectives. Signal Transduct. Target Ther. 7, 141 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"8632_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12883-023-03399-w","volume":"23","author":"T Chang","year":"2023","unstructured":"Chang, T. et al. Neurological disorders associated with COVID-19 in Sri Lanka. BMC Neurol. 23, 351 (2023).","journal-title":"BMC Neurol."},{"key":"8632_CR50","doi-asserted-by":"publisher","first-page":"1499082","DOI":"10.3389\/fimmu.2024.1499082","volume":"15","author":"S Gong","year":"2024","unstructured":"Gong, S. et al. Clinical and immunological features in patients with neuroimmune complications of COVID-19 during Omicron wave in China: A case series. Front. Immunol. 15, 1499082 (2024).","journal-title":"Front. Immunol."},{"key":"8632_CR51","doi-asserted-by":"publisher","first-page":"e16096","DOI":"10.1111\/ene.16096","volume":"31","author":"L Lu","year":"2024","unstructured":"Lu, L. et al. Neurological complications during the omicron COVID-19 wave in China: A cohort study. Eur. J. Neurol. 31, e16096 (2024).","journal-title":"Eur. J. Neurol."},{"key":"8632_CR52","doi-asserted-by":"publisher","first-page":"e29648","DOI":"10.1002\/jmv.29648","volume":"96","author":"S-Y Chen","year":"2024","unstructured":"Chen, S.-Y. et al. Prior COVID-19 vaccination and reduced risk of cerebrovascular diseases among COVID-19 survivors. J. Med. Virol. 96, e29648 (2024).","journal-title":"J. Med. Virol."},{"key":"8632_CR53","doi-asserted-by":"publisher","first-page":"e47272","DOI":"10.2196\/47272","volume":"9","author":"M Liu","year":"2023","unstructured":"Liu, M. et al. Immune-boosting effect of the COVID-19 vaccine: Real-world bidirectional cohort study. JMIR Public Health Surveill. 9, e47272 (2023).","journal-title":"JMIR Public Health Surveill."},{"key":"8632_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbi.2023.03.022","volume":"111","author":"F Ceban","year":"2023","unstructured":"Ceban, F. et al. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Brain Behav. Immun. 111, 211\u2013229 (2023).","journal-title":"Brain Behav. Immun."},{"key":"8632_CR55","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1016\/S2666-5247(23)00171-4","volume":"4","author":"X Zhu","year":"2023","unstructured":"Zhu, X. et al. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: A prospective cohort study. Lancet Microbe 4, e692\u2013e703 (2023).","journal-title":"Lancet Microbe"},{"key":"8632_CR56","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","volume":"26","author":"A Gupta","year":"2020","unstructured":"Gupta, A. et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 26, 1017\u20131032 (2020).","journal-title":"Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08632-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08632-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08632-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T14:02:58Z","timestamp":1751810578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08632-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,6]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8632"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08632-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,6]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Brazilian National Committee of Ethics in Research on April 22, 2020 (Protocol number CAAE 30611720.6.0000.5262), and written informed consent was obtained from all participants. All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"24154"}}